SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cistron Biotechnology(CIST)$.30 -- Ignore unavailable to you. Want to Upgrade?

To: John Metcalf who wrote (2158)5/7/1999 12:21:00 PM
From: Walter Morton  Read Replies (1) | Respond to of 2742
 
I would like to hear that they are filing for FDA approval on something!!!



To: John Metcalf who wrote (2158)5/8/1999 11:03:00 AM
From: Steve Harmon  Read Replies (1) | Respond to of 2742
 
I agree with Richard's "no lose" statement. I have been saying for years that Bruce G. had too many weapons and was "allowing" our shares to meander at bankrupt levels.

Why do you think he is hanging around for a few more weeks and being allowed to do so? Is it the 1.3 million options perhaps?



To: John Metcalf who wrote (2158)5/8/1999 1:53:00 PM
From: Steve Harmon  Respond to of 2742
 
Now you have to know that Genome has to already have a suitor lined up.

1)Naismith has been dealing for Cistron for 18 months.(it is not hard selling a company with $14 million and no debt in this environment)
2)He gets $1 million if he sells Cistron for $1 a share.
3)Several cash poor biotech and medical device would pay a 20-30% premium or 70 cent a share for just Cistron's $13-14 million cash.(By just answering the phone and saying "hello" and "sold".


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News